Wall Street Zen upgraded shares of Acadia Healthcare (NASDAQ:ACHC – Free Report) from a hold rating to a buy rating in a report released on Saturday morning,Wall Street Zen reports.
A number of other research firms have also issued reports on ACHC. Guggenheim increased their price target on shares of Acadia Healthcare from $39.00 to $41.00 and gave the stock a “buy” rating in a research report on Friday. KeyCorp boosted their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Leerink Partners upped their price objective on shares of Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research note on Wednesday, September 23rd. Royal Bank Of Canada increased their target price on shares of Acadia Healthcare from $31.00 to $41.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, TD Cowen lifted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $32.54.
Get Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Price Performance
Shares of NASDAQ:ACHC opened at $38.61 on Friday. The company’s fifty day moving average is $29.61 and its two-hundred day moving average is $26.26. The company has a market cap of $3.59 billion, a P/E ratio of -3.10, a price-to-earnings-growth ratio of 10.39 and a beta of 0.64. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $39.70. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.46 by $0.14. Acadia Healthcare had a positive return on equity of 6.58% and a negative net margin of 33.07%. The business had revenue of $895.31 million during the quarter, compared to analysts’ expectations of $877.76 million. During the same quarter last year, the firm posted $0.72 earnings per share. Acadia Healthcare’s revenue was up 5.1% compared to the same quarter last year. Equities analysts expect that Acadia Healthcare will post 1.75 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
A number of hedge funds have recently added to or reduced their stakes in ACHC. BlackRock Inc. bought a new position in Acadia Healthcare during the second quarter valued at approximately $441,685,000. Jefferies Financial Group Inc. grew its position in Acadia Healthcare by 2.7% in the third quarter. Jefferies Financial Group Inc. now owns 3,703,240 shares of the company’s stock worth $101,839,000 after acquiring an additional 98,173 shares in the last quarter. First Trust Advisors LP increased its stake in shares of Acadia Healthcare by 73.0% during the 1st quarter. First Trust Advisors LP now owns 1,689,442 shares of the company’s stock worth $39,516,000 after purchasing an additional 712,852 shares during the last quarter. Deutsche Bank AG acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth $49,746,000. Finally, Maverick Capital Ltd. raised its holdings in shares of Acadia Healthcare by 45.1% during the 1st quarter. Maverick Capital Ltd. now owns 1,314,116 shares of the company’s stock valued at $30,737,000 after purchasing an additional 408,697 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care.
Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program.
Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
Further Reading
- Five stocks we like better than Acadia Healthcare
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
